 | • レポートコード：GIR-107A12666 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、網膜色素変性症治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。網膜色素変性症治療の種類別市場規模（BNP-RP、セネゲルミン、CPK-850、クタメシン、FAB-111、その他）、用途別市場規模（病院、クリニック、在宅ケア）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・網膜色素変性症治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Astellas Pharma Inc.、Caladrius Biosciences, Inc.、Dompe Farmaceutici S.p.A.、Genable Technologies Limited、Genethon、GenSight Biologics S.A.、Grupo Ferrer Internacional, S.A.、ID Pharma Co., Ltd.、InFlectis BioScience、International Stem Cell Corporation、Ionis Pharmaceuticals, Inc.、M's Science Corporation、Mimetogen Pharmaceuticals Inc.、Nanovector s.r.l.、Orphagen Pharmaceuticals, Inc. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：BNP-RP、セネゲルミン、CPK-850、クタメシン、FAB-111、その他 ・用途別分析2016年-2026年：病院、クリニック、在宅ケア ・網膜色素変性症治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・網膜色素変性症治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・網膜色素変性症治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・網膜色素変性症治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・網膜色素変性症治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Retinitis Pigmentosa Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Retinitis Pigmentosa Treatment size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Retinitis Pigmentosa Treatment market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Retinitis Pigmentosa Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
BNP-RP
Cenegermin
CPK-850
Cutamesine
FAB-111
Others
Market segment by Application, can be divided into
Hospital
Clinic
Homecare
Market segment by players, this report covers
Astellas Pharma Inc.
Caladrius Biosciences, Inc.
Dompe Farmaceutici S.p.A.
Genable Technologies Limited
Genethon
GenSight Biologics S.A.
Grupo Ferrer Internacional, S.A.
ID Pharma Co., Ltd.
InFlectis BioScience
International Stem Cell Corporation
Ionis Pharmaceuticals, Inc.
M’s Science Corporation
Mimetogen Pharmaceuticals Inc.
Nanovector s.r.l.
Orphagen Pharmaceuticals, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Retinitis Pigmentosa Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Retinitis Pigmentosa Treatment, with revenue, gross margin and global market share of Retinitis Pigmentosa Treatment from 2019 to 2021.
Chapter 3, the Retinitis Pigmentosa Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Retinitis Pigmentosa Treatment market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Retinitis Pigmentosa Treatment research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Retinitis Pigmentosa Treatment
1.2 Classification of Retinitis Pigmentosa Treatment by Type
1.2.1 Overview: Global Retinitis Pigmentosa Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Retinitis Pigmentosa Treatment Revenue Market Share by Type in 2020
1.2.3 BNP-RP
1.2.4 Cenegermin
1.2.5 CPK-850
1.2.6 Cutamesine
1.2.7 FAB-111
1.2.8 Others
1.3 Global Retinitis Pigmentosa Treatment Market by Application
1.3.1 Overview: Global Retinitis Pigmentosa Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Homecare
1.4 Global Retinitis Pigmentosa Treatment Market Size & Forecast
1.5 Global Retinitis Pigmentosa Treatment Market Size and Forecast by Region
1.5.1 Global Retinitis Pigmentosa Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Retinitis Pigmentosa Treatment Market Size by Region, (2016-2021)
1.5.3 North America Retinitis Pigmentosa Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe Retinitis Pigmentosa Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Retinitis Pigmentosa Treatment Market Size and Prospect (2016-2026)
1.5.6 South America Retinitis Pigmentosa Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Retinitis Pigmentosa Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Retinitis Pigmentosa Treatment Market Drivers
1.6.2 Retinitis Pigmentosa Treatment Market Restraints
1.6.3 Retinitis Pigmentosa Treatment Trends Analysis
2 Company Profiles
2.1 Astellas Pharma Inc.
2.1.1 Astellas Pharma Inc. Details
2.1.2 Astellas Pharma Inc. Major Business
2.1.3 Astellas Pharma Inc. Retinitis Pigmentosa Treatment Product and Solutions
2.1.4 Astellas Pharma Inc. Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Astellas Pharma Inc. Recent Developments and Future Plans
2.2 Caladrius Biosciences, Inc.
2.2.1 Caladrius Biosciences, Inc. Details
2.2.2 Caladrius Biosciences, Inc. Major Business
2.2.3 Caladrius Biosciences, Inc. Retinitis Pigmentosa Treatment Product and Solutions
2.2.4 Caladrius Biosciences, Inc. Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Caladrius Biosciences, Inc. Recent Developments and Future Plans
2.3 Dompe Farmaceutici S.p.A.
2.3.1 Dompe Farmaceutici S.p.A. Details
2.3.2 Dompe Farmaceutici S.p.A. Major Business
2.3.3 Dompe Farmaceutici S.p.A. Retinitis Pigmentosa Treatment Product and Solutions
2.3.4 Dompe Farmaceutici S.p.A. Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Dompe Farmaceutici S.p.A. Recent Developments and Future Plans
2.4 Genable Technologies Limited
2.4.1 Genable Technologies Limited Details
2.4.2 Genable Technologies Limited Major Business
2.4.3 Genable Technologies Limited Retinitis Pigmentosa Treatment Product and Solutions
2.4.4 Genable Technologies Limited Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Genable Technologies Limited Recent Developments and Future Plans
2.5 Genethon
2.5.1 Genethon Details
2.5.2 Genethon Major Business
2.5.3 Genethon Retinitis Pigmentosa Treatment Product and Solutions
2.5.4 Genethon Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Genethon Recent Developments and Future Plans
2.6 GenSight Biologics S.A.
2.6.1 GenSight Biologics S.A. Details
2.6.2 GenSight Biologics S.A. Major Business
2.6.3 GenSight Biologics S.A. Retinitis Pigmentosa Treatment Product and Solutions
2.6.4 GenSight Biologics S.A. Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 GenSight Biologics S.A. Recent Developments and Future Plans
2.7 Grupo Ferrer Internacional, S.A.
2.7.1 Grupo Ferrer Internacional, S.A. Details
2.7.2 Grupo Ferrer Internacional, S.A. Major Business
2.7.3 Grupo Ferrer Internacional, S.A. Retinitis Pigmentosa Treatment Product and Solutions
2.7.4 Grupo Ferrer Internacional, S.A. Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Grupo Ferrer Internacional, S.A. Recent Developments and Future Plans
2.8 ID Pharma Co., Ltd.
2.8.1 ID Pharma Co., Ltd. Details
2.8.2 ID Pharma Co., Ltd. Major Business
2.8.3 ID Pharma Co., Ltd. Retinitis Pigmentosa Treatment Product and Solutions
2.8.4 ID Pharma Co., Ltd. Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 ID Pharma Co., Ltd. Recent Developments and Future Plans
2.9 InFlectis BioScience
2.9.1 InFlectis BioScience Details
2.9.2 InFlectis BioScience Major Business
2.9.3 InFlectis BioScience Retinitis Pigmentosa Treatment Product and Solutions
2.9.4 InFlectis BioScience Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 InFlectis BioScience Recent Developments and Future Plans
2.10 International Stem Cell Corporation
2.10.1 International Stem Cell Corporation Details
2.10.2 International Stem Cell Corporation Major Business
2.10.3 International Stem Cell Corporation Retinitis Pigmentosa Treatment Product and Solutions
2.10.4 International Stem Cell Corporation Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 International Stem Cell Corporation Recent Developments and Future Plans
2.11 Ionis Pharmaceuticals, Inc.
2.11.1 Ionis Pharmaceuticals, Inc. Details
2.11.2 Ionis Pharmaceuticals, Inc. Major Business
2.11.3 Ionis Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Product and Solutions
2.11.4 Ionis Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Ionis Pharmaceuticals, Inc. Recent Developments and Future Plans
2.12 M’s Science Corporation
2.12.1 M’s Science Corporation Details
2.12.2 M’s Science Corporation Major Business
2.12.3 M’s Science Corporation Retinitis Pigmentosa Treatment Product and Solutions
2.12.4 M’s Science Corporation Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 M’s Science Corporation Recent Developments and Future Plans
2.13 Mimetogen Pharmaceuticals Inc.
2.13.1 Mimetogen Pharmaceuticals Inc. Details
2.13.2 Mimetogen Pharmaceuticals Inc. Major Business
2.13.3 Mimetogen Pharmaceuticals Inc. Retinitis Pigmentosa Treatment Product and Solutions
2.13.4 Mimetogen Pharmaceuticals Inc. Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Mimetogen Pharmaceuticals Inc. Recent Developments and Future Plans
2.14 Nanovector s.r.l.
2.14.1 Nanovector s.r.l. Details
2.14.2 Nanovector s.r.l. Major Business
2.14.3 Nanovector s.r.l. Retinitis Pigmentosa Treatment Product and Solutions
2.14.4 Nanovector s.r.l. Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Nanovector s.r.l. Recent Developments and Future Plans
2.15 Orphagen Pharmaceuticals, Inc.
2.15.1 Orphagen Pharmaceuticals, Inc. Details
2.15.2 Orphagen Pharmaceuticals, Inc. Major Business
2.15.3 Orphagen Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Product and Solutions
2.15.4 Orphagen Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Orphagen Pharmaceuticals, Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Retinitis Pigmentosa Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Retinitis Pigmentosa Treatment Players Market Share
3.2.2 Top 10 Retinitis Pigmentosa Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 Retinitis Pigmentosa Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Retinitis Pigmentosa Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global Retinitis Pigmentosa Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Retinitis Pigmentosa Treatment Revenue Market Share by Application (2016-2021)
5.2 Retinitis Pigmentosa Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Retinitis Pigmentosa Treatment Revenue by Type (2016-2026)
6.2 North America Retinitis Pigmentosa Treatment Revenue by Application (2016-2026)
6.3 North America Retinitis Pigmentosa Treatment Market Size by Country
6.3.1 North America Retinitis Pigmentosa Treatment Revenue by Country (2016-2026)
6.3.2 United States Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Retinitis Pigmentosa Treatment Revenue by Type (2016-2026)
7.2 Europe Retinitis Pigmentosa Treatment Revenue by Application (2016-2026)
7.3 Europe Retinitis Pigmentosa Treatment Market Size by Country
7.3.1 Europe Retinitis Pigmentosa Treatment Revenue by Country (2016-2026)
7.3.2 Germany Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)
7.3.3 France Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Retinitis Pigmentosa Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific Retinitis Pigmentosa Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific Retinitis Pigmentosa Treatment Market Size by Region
8.3.1 Asia-Pacific Retinitis Pigmentosa Treatment Revenue by Region (2016-2026)
8.3.2 China Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)
8.3.5 India Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Retinitis Pigmentosa Treatment Revenue by Type (2016-2026)
9.2 South America Retinitis Pigmentosa Treatment Revenue by Application (2016-2026)
9.3 South America Retinitis Pigmentosa Treatment Market Size by Country
9.3.1 South America Retinitis Pigmentosa Treatment Revenue by Country (2016-2026)
9.3.2 Brazil Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Retinitis Pigmentosa Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa Retinitis Pigmentosa Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa Retinitis Pigmentosa Treatment Market Size by Country
10.3.1 Middle East & Africa Retinitis Pigmentosa Treatment Revenue by Country (2016-2026)
10.3.2 Turkey Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Retinitis Pigmentosa Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Retinitis Pigmentosa Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Retinitis Pigmentosa Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Retinitis Pigmentosa Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global Retinitis Pigmentosa Treatment Revenue Market Share by Region (2021-2026)
Table 6. Astellas Pharma Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Astellas Pharma Inc. Major Business
Table 8. Astellas Pharma Inc. Retinitis Pigmentosa Treatment Product and Solutions
Table 9. Astellas Pharma Inc. Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Caladrius Biosciences, Inc. Corporate Information, Head Office, and Major Competitors
Table 11. Caladrius Biosciences, Inc. Major Business
Table 12. Caladrius Biosciences, Inc. Retinitis Pigmentosa Treatment Product and Solutions
Table 13. Caladrius Biosciences, Inc. Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Dompe Farmaceutici S.p.A. Corporate Information, Head Office, and Major Competitors
Table 15. Dompe Farmaceutici S.p.A. Major Business
Table 16. Dompe Farmaceutici S.p.A. Retinitis Pigmentosa Treatment Product and Solutions
Table 17. Dompe Farmaceutici S.p.A. Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Genable Technologies Limited Corporate Information, Head Office, and Major Competitors
Table 19. Genable Technologies Limited Major Business
Table 20. Genable Technologies Limited Retinitis Pigmentosa Treatment Product and Solutions
Table 21. Genable Technologies Limited Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Genethon Corporate Information, Head Office, and Major Competitors
Table 23. Genethon Major Business
Table 24. Genethon Retinitis Pigmentosa Treatment Product and Solutions
Table 25. Genethon Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. GenSight Biologics S.A. Corporate Information, Head Office, and Major Competitors
Table 27. GenSight Biologics S.A. Major Business
Table 28. GenSight Biologics S.A. Retinitis Pigmentosa Treatment Product and Solutions
Table 29. GenSight Biologics S.A. Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Grupo Ferrer Internacional, S.A. Corporate Information, Head Office, and Major Competitors
Table 31. Grupo Ferrer Internacional, S.A. Major Business
Table 32. Grupo Ferrer Internacional, S.A. Retinitis Pigmentosa Treatment Product and Solutions
Table 33. Grupo Ferrer Internacional, S.A. Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. ID Pharma Co., Ltd. Corporate Information, Head Office, and Major Competitors
Table 35. ID Pharma Co., Ltd. Major Business
Table 36. ID Pharma Co., Ltd. Retinitis Pigmentosa Treatment Product and Solutions
Table 37. ID Pharma Co., Ltd. Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. InFlectis BioScience Corporate Information, Head Office, and Major Competitors
Table 39. InFlectis BioScience Major Business
Table 40. InFlectis BioScience Retinitis Pigmentosa Treatment Product and Solutions
Table 41. InFlectis BioScience Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. International Stem Cell Corporation Corporate Information, Head Office, and Major Competitors
Table 43. International Stem Cell Corporation Major Business
Table 44. International Stem Cell Corporation Retinitis Pigmentosa Treatment Product and Solutions
Table 45. International Stem Cell Corporation Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Ionis Pharmaceuticals, Inc. Corporate Information, Head Office, and Major Competitors
Table 47. Ionis Pharmaceuticals, Inc. Major Business
Table 48. Ionis Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Product and Solutions
Table 49. Ionis Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. M's Science Corporation Corporate Information, Head Office, and Major Competitors
Table 51. M's Science Corporation Major Business
Table 52. M's Science Corporation Retinitis Pigmentosa Treatment Product and Solutions
Table 53. M's Science Corporation Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Mimetogen Pharmaceuticals Inc. Corporate Information, Head Office, and Major Competitors
Table 55. Mimetogen Pharmaceuticals Inc. Major Business
Table 56. Mimetogen Pharmaceuticals Inc. Retinitis Pigmentosa Treatment Product and Solutions
Table 57. Mimetogen Pharmaceuticals Inc. Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Nanovector s.r.l. Corporate Information, Head Office, and Major Competitors
Table 59. Nanovector s.r.l. Major Business
Table 60. Nanovector s.r.l. Retinitis Pigmentosa Treatment Product and Solutions
Table 61. Nanovector s.r.l. Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Orphagen Pharmaceuticals, Inc. Corporate Information, Head Office, and Major Competitors
Table 63. Orphagen Pharmaceuticals, Inc. Major Business
Table 64. Orphagen Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Product and Solutions
Table 65. Orphagen Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Global Retinitis Pigmentosa Treatment Revenue (USD Million) by Players (2019-2021)
Table 67. Global Retinitis Pigmentosa Treatment Revenue Share by Players (2019-2021)
Table 68. Breakdown of Retinitis Pigmentosa Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. Retinitis Pigmentosa Treatment Players Head Office, Products and Services Provided
Table 70. Retinitis Pigmentosa Treatment Mergers & Acquisitions in the Past Five Years
Table 71. Retinitis Pigmentosa Treatment New Entrants and Expansion Plans
Table 72. Global Retinitis Pigmentosa Treatment Revenue (USD Million) by Type (2016-2021)
Table 73. Global Retinitis Pigmentosa Treatment Revenue Share by Type (2016-2021)
Table 74. Global Retinitis Pigmentosa Treatment Revenue Forecast by Type (2021-2026)
Table 75. Global Retinitis Pigmentosa Treatment Revenue by Application (2016-2021)
Table 76. Global Retinitis Pigmentosa Treatment Revenue Forecast by Application (2021-2026)
Table 77. North America Retinitis Pigmentosa Treatment Revenue by Type (2016-2021) & (USD Million)
Table 78. North America Retinitis Pigmentosa Treatment Revenue by Type (2021-2026) & (USD Million)
Table 79. North America Retinitis Pigmentosa Treatment Revenue by Application (2016-2021) & (USD Million)
Table 80. North America Retinitis Pigmentosa Treatment Revenue by Application (2021-2026) & (USD Million)
Table 81. North America Retinitis Pigmentosa Treatment Revenue by Country (2016-2021) & (USD Million)
Table 82. North America Retinitis Pigmentosa Treatment Revenue by Country (2021-2026) & (USD Million)
Table 83. Europe Retinitis Pigmentosa Treatment Revenue by Type (2016-2021) & (USD Million)
Table 84. Europe Retinitis Pigmentosa Treatment Revenue by Type (2021-2026) & (USD Million)
Table 85. Europe Retinitis Pigmentosa Treatment Revenue by Application (2016-2021) & (USD Million)
Table 86. Europe Retinitis Pigmentosa Treatment Revenue by Application (2021-2026) & (USD Million)
Table 87. Europe Retinitis Pigmentosa Treatment Revenue by Country (2016-2021) & (USD Million)
Table 88. Europe Retinitis Pigmentosa Treatment Revenue by Country (2021-2026) & (USD Million)
Table 89. Asia-Pacific Retinitis Pigmentosa Treatment Revenue by Type (2016-2021) & (USD Million)
Table 90. Asia-Pacific Retinitis Pigmentosa Treatment Revenue by Type (2021-2026) & (USD Million)
Table 91. Asia-Pacific Retinitis Pigmentosa Treatment Revenue by Application (2016-2021) & (USD Million)
Table 92. Asia-Pacific Retinitis Pigmentosa Treatment Revenue by Application (2021-2026) & (USD Million)
Table 93. Asia-Pacific Retinitis Pigmentosa Treatment Revenue by Region (2016-2021) & (USD Million)
Table 94. Asia-Pacific Retinitis Pigmentosa Treatment Revenue by Region (2021-2026) & (USD Million)
Table 95. South America Retinitis Pigmentosa Treatment Revenue by Type (2016-2021) & (USD Million)
Table 96. South America Retinitis Pigmentosa Treatment Revenue by Type (2021-2026) & (USD Million)
Table 97. South America Retinitis Pigmentosa Treatment Revenue by Application (2016-2021) & (USD Million)
Table 98. South America Retinitis Pigmentosa Treatment Revenue by Application (2021-2026) & (USD Million)
Table 99. South America Retinitis Pigmentosa Treatment Revenue by Country (2016-2021) & (USD Million)
Table 100. South America Retinitis Pigmentosa Treatment Revenue by Country (2021-2026) & (USD Million)
Table 101. Middle East & Africa Retinitis Pigmentosa Treatment Revenue by Type (2016-2021) & (USD Million)
Table 102. Middle East & Africa Retinitis Pigmentosa Treatment Revenue by Type (2021-2026) & (USD Million)
Table 103. Middle East & Africa Retinitis Pigmentosa Treatment Revenue by Application (2016-2021) & (USD Million)
Table 104. Middle East & Africa Retinitis Pigmentosa Treatment Revenue by Application (2021-2026) & (USD Million)
Table 105. Middle East & Africa Retinitis Pigmentosa Treatment Revenue by Country (2016-2021) & (USD Million)
Table 106. Middle East & Africa Retinitis Pigmentosa Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Retinitis Pigmentosa Treatment Picture
Figure 2. Global Retinitis Pigmentosa Treatment Revenue Market Share by Type in 2020
Figure 3. BNP-RP
Figure 4. Cenegermin
Figure 5. CPK-850
Figure 6. Cutamesine
Figure 7. FAB-111
Figure 8. Others
Figure 9. Retinitis Pigmentosa Treatment Revenue Market Share by Application in 2020
Figure 10. Hospital Picture
Figure 11. Clinic Picture
Figure 12. Homecare Picture
Figure 13. Global Retinitis Pigmentosa Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 14. Global Retinitis Pigmentosa Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 15. Global Retinitis Pigmentosa Treatment Revenue Market Share by Region (2016-2026)
Figure 16. Global Retinitis Pigmentosa Treatment Revenue Market Share by Region in 2020
Figure 17. North America Retinitis Pigmentosa Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Europe Retinitis Pigmentosa Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Asia-Pacific Retinitis Pigmentosa Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. South America Retinitis Pigmentosa Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Middle East and Africa Retinitis Pigmentosa Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Retinitis Pigmentosa Treatment Market Drivers
Figure 23. Retinitis Pigmentosa Treatment Market Restraints
Figure 24. Retinitis Pigmentosa Treatment Market Trends
Figure 25. Astellas Pharma Inc. Recent Developments and Future Plans
Figure 26. Caladrius Biosciences, Inc. Recent Developments and Future Plans
Figure 27. Dompe Farmaceutici S.p.A. Recent Developments and Future Plans
Figure 28. Genable Technologies Limited Recent Developments and Future Plans
Figure 29. Genethon Recent Developments and Future Plans
Figure 30. GenSight Biologics S.A. Recent Developments and Future Plans
Figure 31. Grupo Ferrer Internacional, S.A. Recent Developments and Future Plans
Figure 32. ID Pharma Co., Ltd. Recent Developments and Future Plans
Figure 33. InFlectis BioScience Recent Developments and Future Plans
Figure 34. International Stem Cell Corporation Recent Developments and Future Plans
Figure 35. Ionis Pharmaceuticals, Inc. Recent Developments and Future Plans
Figure 36. M's Science Corporation Recent Developments and Future Plans
Figure 37. Mimetogen Pharmaceuticals Inc. Recent Developments and Future Plans
Figure 38. Nanovector s.r.l. Recent Developments and Future Plans
Figure 39. Orphagen Pharmaceuticals, Inc. Recent Developments and Future Plans
Figure 40. Global Retinitis Pigmentosa Treatment Revenue Share by Players in 2020
Figure 41. Retinitis Pigmentosa Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 42. Global Top 3 Players Retinitis Pigmentosa Treatment Revenue Market Share in 2020
Figure 43. Global Top 10 Players Retinitis Pigmentosa Treatment Revenue Market Share in 2020
Figure 44. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 45. Global Retinitis Pigmentosa Treatment Revenue Share by Type in 2020
Figure 46. Global Retinitis Pigmentosa Treatment Market Share Forecast by Type (2021-2026)
Figure 47. Global Retinitis Pigmentosa Treatment Revenue Share by Application in 2020
Figure 48. Global Retinitis Pigmentosa Treatment Market Share Forecast by Application (2021-2026)
Figure 49. North America Retinitis Pigmentosa Treatment Sales Market Share by Type (2016-2026)
Figure 50. North America Retinitis Pigmentosa Treatment Sales Market Share by Application (2016-2026)
Figure 51. North America Retinitis Pigmentosa Treatment Revenue Market Share by Country (2016-2026)
Figure 52. United States Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Canada Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Mexico Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Europe Retinitis Pigmentosa Treatment Sales Market Share by Type (2016-2026)
Figure 56. Europe Retinitis Pigmentosa Treatment Sales Market Share by Application (2016-2026)
Figure 57. Europe Retinitis Pigmentosa Treatment Revenue Market Share by Country (2016-2026)
Figure 58. Germany Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. France Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. United Kingdom Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Russia Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Italy Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Asia-Pacific Retinitis Pigmentosa Treatment Sales Market Share by Type (2016-2026)
Figure 64. Asia-Pacific Retinitis Pigmentosa Treatment Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific Retinitis Pigmentosa Treatment Revenue Market Share by Region (2016-2026)
Figure 66. China Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Japan Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South Korea Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. India Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Southeast Asia Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Australia Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. South America Retinitis Pigmentosa Treatment Sales Market Share by Type (2016-2026)
Figure 73. South America Retinitis Pigmentosa Treatment Sales Market Share by Application (2016-2026)
Figure 74. South America Retinitis Pigmentosa Treatment Revenue Market Share by Country (2016-2026)
Figure 75. Brazil Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Argentina Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Middle East and Africa Retinitis Pigmentosa Treatment Sales Market Share by Type (2016-2026)
Figure 78. Middle East and Africa Retinitis Pigmentosa Treatment Sales Market Share by Application (2016-2026)
Figure 79. Middle East and Africa Retinitis Pigmentosa Treatment Revenue Market Share by Country (2016-2026)
Figure 80. Turkey Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Saudi Arabia Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. UAE Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. Methodology
Figure 84. Research Process and Data Source
世界の多汗症治療市場 2021：企業別、地域別、種類・用途別 The Hyperhidrosis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…- 世界のレイノー病治療市場 2021：企業別、地域別、種類・用途別 The Raynauds Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…
- 世界の神経性過食症治療市場 2021：企業別、地域別、種類・用途別 The Bulimia Nervosa Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…
- 世界のダンピング症候群治療市場 2021：企業別、地域別、種類・用途別 The Dumping Syndrome Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…
- 世界の色素脱失障害治療市場 2021：企業別、地域別、種類・用途別 The Hypopigmentation Disorder Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…